Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker-Reference-Cited by-同舟云学术

Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker

Published:2008-04-08 Issue:0 Volume:0 Page:080408163539339-???
ISSN:1015-6305
Container-title:Brain Pathology
language:en
Short-container-title:Brain Pathology

Author:

Preusser Matthias,Charles Janzer Robert,Felsberg Jörg,Reifenberger Guido,Hamou Marie-France,Diserens Annie-Claire,Stupp Roger,Gorlia Thierry,Marosi Christine,Heinzl Harald,Hainfellner Johannes A,Hegi Monika

Publisher

Wiley

Subject

Clinical Neurology,Pathology and Forensic Medicine,General Neuroscience

Reference57 articles.

1. Relationship between expression of O6-methylguanine-DNA methyltransferase, glutathione-S-transferase π in glioblastoma and the survival of the patients treated with nimustine hydrochloride: An immunohistochemical analysis

2. Activation of human O6-methylguanine-DNA methyltransferase gene by glucocorticoid hormone

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What scRNA sequencing taught us about MGMT expression in glioblastoma;2024-07-24

2. MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-03

3. Consensus guidelines for the management of adult low-grade gliomas for low and middle-income countries;J PAK MED ASSOC;2024

4. Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors: The Phase II SONNET Study;The Oncologist;2024-01-11

5. A chloromethyl-triazole fluorescent chemosensor for O⁶-methylguanine DNA methyltransferase;Organic & Biomolecular Chemistry;2024